Harold Kleanthous

1.1k total citations
14 papers, 803 citations indexed

About

Harold Kleanthous is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Harold Kleanthous has authored 14 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Harold Kleanthous's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Harold Kleanthous is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Harold Kleanthous collaborates with scholars based in United States, France and Australia. Harold Kleanthous's co-authors include Richard Weltzin, Cynthia Lee, Thomas P. Monath, Paul J. Giannasca, Richard Nichols, John G. Nedrud, Thomas H. Ermak, Gwendolyn A. Myers, Ted M. Ross and Timothy Alefantis and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Harold Kleanthous

14 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold Kleanthous United States 10 434 353 350 183 162 14 803
Gwendolyn A. Myers United States 9 389 0.9× 137 0.4× 413 1.2× 374 2.0× 201 1.2× 9 989
Erica Borgogni Italy 10 481 1.1× 236 0.7× 72 0.2× 125 0.7× 23 0.1× 12 694
Robert Morrison United States 10 519 1.2× 473 1.3× 117 0.3× 102 0.6× 28 0.2× 17 1.2k
V Giannelli Italy 8 457 1.1× 124 0.4× 129 0.4× 263 1.4× 71 0.4× 8 722
Audrey Tanghe France 12 484 1.1× 583 1.7× 57 0.2× 706 3.9× 132 0.8× 12 1.0k
Michelle Thom United Kingdom 19 369 0.9× 517 1.5× 63 0.2× 511 2.8× 53 0.3× 21 909
Jon D. Gabbard United States 17 187 0.4× 373 1.1× 59 0.2× 262 1.4× 142 0.9× 29 671
Farzad O. Olfat Singapore 8 269 0.6× 91 0.3× 217 0.6× 178 1.0× 49 0.3× 10 636
Marc Fourneau Belgium 8 259 0.6× 606 1.7× 83 0.2× 321 1.8× 46 0.3× 13 1.0k
Laurens A.H. van Pinxteren Denmark 9 584 1.3× 607 1.7× 205 0.6× 952 5.2× 27 0.2× 13 1.2k

Countries citing papers authored by Harold Kleanthous

Since Specialization
Citations

This map shows the geographic impact of Harold Kleanthous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Kleanthous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Kleanthous more than expected).

Fields of papers citing papers by Harold Kleanthous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Kleanthous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Kleanthous. The network helps show where Harold Kleanthous may publish in the future.

Co-authorship network of co-authors of Harold Kleanthous

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Kleanthous. A scholar is included among the top collaborators of Harold Kleanthous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Kleanthous. Harold Kleanthous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Groppo, Rachel, Joshua M. DiNapoli, Michael Kishko, et al.. (2018). Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine. PLoS ONE. 13(6). e0199452–e0199452. 9 indexed citations
2.
Giel–Moloney, Maryann, Ana P. Goncalvez, John Catalan, et al.. (2018). Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine. Scientific Reports. 8(1). 13206–13206. 31 indexed citations
3.
Allen, James D., Hyesun Jang, Joshua M. DiNapoli, Harold Kleanthous, & Ted M. Ross. (2018). Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses. Journal of Virology. 93(3). 43 indexed citations
4.
Akkina, Ramesh, Heinz Ellerbrok, William W. Hall, et al.. (2017). 2016 International meeting of the Global Virus Network. Antiviral Research. 142. 21–29. 4 indexed citations
5.
Wong, Terianne, James D. Allen, Donald M. Carter, et al.. (2017). Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants. Journal of Virology. 91(24). 79 indexed citations
6.
Carter, Donald M., Corey J. Crevar, Timothy Alefantis, et al.. (2016). Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. Journal of Virology. 90(9). 4720–4734. 144 indexed citations
7.
Reynolds, Eric C., Neil M. O’Brien‐Simpson, Tony Rowe, et al.. (2015). Prospects for treatment of Porphyromonas gingivalis-mediated disease – immune-based therapy. Journal of Oral Microbiology. 7(1). 29125–29125. 8 indexed citations
8.
Kalnin, Kirill V., Timothy Tibbitts, Yanhua Yan, et al.. (2014). Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes. Vaccine. 32(28). 3540–3547. 38 indexed citations
9.
Hernandez, Hector Lopez, et al.. (2013). Analysis of the humoral immune response to HSV-2 glycoproteins in ACAM529-vaccinated mice. (P4519). The Journal of Immunology. 190(Supplement_1). 179.22–179.22. 1 indexed citations
10.
Jagu, Subhashini, Kihyuck Kwak, John T. Schiller, et al.. (2013). Phylogenetic Considerations in Designing a Broadly Protective Multimeric L2 Vaccine. Journal of Virology. 87(11). 6127–6136. 31 indexed citations
11.
Rumyantsev, Alexander A., Maryann Giel–Moloney, Yuxi Liu, et al.. (2011). Characterization of the RepliVax platform for replication-defective flavivirus vaccines. Vaccine. 29(32). 5184–5194. 12 indexed citations
12.
Rumyantsev, Alexander A., Zhenxi Zhang, Qingsheng Gao, et al.. (2009). Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Virology. 396(2). 329–338. 14 indexed citations
13.
Ermak, Thomas H., Paul J. Giannasca, Richard Nichols, et al.. (1998). Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses. The Journal of Experimental Medicine. 188(12). 2277–2288. 322 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026